IV Stabilization Devices to Witness Decline in Demand By 2025

IV administration technique is used for correcting dehydration or electrolyte imbalance, for blood transfusions, and to deliver medication. The peripheral infusion devices are the most commonly used devices in the global medical market. The IV stabilization devices are used with the medical tubes and catheters for increasing the dwell time of the catheter along with providing protection to the site with proper visibility, dressing integrity and stability of IV device. IV stabilization devices secure the neonatal skin with minimum catheter micro motion and increases patient comfort and safety. It also reduces the catheter associated complication, including dislodgement and itching. With the comprehensive application of IV therapy, Center for Disease Control (CDC) has issued proper guidelines for IV stabilization devices ensuring proper safety and comfort to the patients.

The high prevalence of prolonged and lifestyle associated disorders such as cardiovascular disorders, chronic renal failure, and cancer lead to numerous surgeries. These are projected to spur demand for catheter, eventually boosting the IV stabilization device market globally. The growing geriatric population, healthcare expenditure, increased demand for minimally invasive surgeries owing to reduced pain, increased patient satisfaction, and faster recovery are some major factors that drive growth of the global IV stabilization device market. The problems such as hematoma, infiltration, extravascular drug administration or phlebitis while using IV therapy, restrain the use of IV administration technique, thereby affecting the global market of IV stabilization devices. However, with increasing incidences, and substantial increase in healthcare spending, the IV stabilization devices market is expected to increase over the forecast period.

The global IV stabilization device market is segmented on the basis of product, application, age group, end user and geography.On the basis of product, the global IV stabilization device market is segmented as:Central Venous Catheter Stabilization Device,Peripheral Stabilization Devices,Abdominal Drainage Tubes Securement Devices,Epidural Stabilization Devices,Chest Drainage Tube Stabilization Devices

On the basis of application, the global IV stabilization device market is segmented as:General surgery,Cardiovascular,Respiratory,Urological,Gastric,Pharyngeal,Radiology,Other;On the basis of age group, the global IV stabilization device market is segmented as:Pediatric,Adult;On the basis of end user, the global IV stabilization device market is segmented as:Hospitals,Emergency Clinics,Home Healthcare Providers,Diagnostic Centers;

The Global IV stabilization device market it completely dependent on IV therapy practice. With the surge in the IV therapy usage, the global IV stabilization device market is projected to experience a hike. On the basis of end user the global IV stabilization device market is segmented as hospitals, emergency clinics, diagnostic centers and home healthcare providers. Admittedly, hospital segment holds the largest share of the market. The global market of IV stabilization devices is also segmented on the basis of age group. Different catheters are used in pediatrics and adults for IV infusion, thereby inducing the need of different IV stabilization devices.

On the basis of geography, the global market of IV stabilization device market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America holds the largest share of global IV stabilization device market owing to the presence of good reimbursement scenario and health facilities. Europe holds the second largest share, followed by Asia Pacific. With the increasing geriatric population and number of service providers in the Asia Pacific and Middle Eastern Countries, the global IV stabilization device market is expected to grow in these regions.

Some leading players in the global IV stabilization device market include Medtronic plc, 3M Company, C. R. Bard, Baxter International, Inc., B. Braun Melsungen AG, ConvaTec Inc., Smiths Group plc, and M.C. Johnson Company, Inc.

A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/18265